Delivery Order SPE2DB20D7066-SPE2DB25FC4LW
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,005.60 for 500 mg/5 mL ketamine vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical product for federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,817,954 units of Ketamine 200 mg/20 ml vials with a completion date of March 1, 2024 and a potential value of $1,501.50. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ketamine 500mg/5mL in quantities of 10, with a ceiling value of $1,076.58 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,540.20 firm fixed-price delivery order is for the supply of 500 mg/5 ml vials of the drug Ketamine. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $2,530.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 500 mg/10 mL vials of the injectable anesthetic medication Ketamine. The contract has a completion date of February 12, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and sole awardee on this delivery order. The contract is not associated with any...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,342.62 firm fixed-price delivery order is for the supply of Ketamine 500 mg/10 ml vials. The contract has an ultimate completion date of April 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,025.45 from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 200 mg/20 ml vials of ketamine. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by November 7, 2023. No set-aside designation was applied to this award made under the prime vendor's existing...
- The Defense Logistics Agency awarded a $77,120 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for ketamine hydrochloride injection USP, 500 mg/5mL vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 5, 2023 in support of the Agency's medical supply needs. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, awarded without set-aside provisions through competitive procurement, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contractor will perform the work at its corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4LWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,651.52 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 mL vials. This firm fixed-price contract, awarded on August 22, 2025, represents a competitive procurement with no set-aside designation and carries an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order reflects AmerisourceBergen's established role as a critical federal pharmaceutical vendor, with its contract portfolio demonstrating consistent capability to fulfill competitive federal medical procurement requirements across therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/22/25 |